Relay Therapeutics is a clinical-stage small molecule precision medicine company developing therapies for cancer and genetic disease. Its proprietary Dynamo platform integrates computational and experimental approaches to drug previously intractable protein targets. Key pipeline candidates include RLY-2608 (PI3Kα inhibitor) and RLY-4008 (FGFR2 inhibitor), targeting genetically defined patient populations with unmet medical needs.
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076739 | EDGAR | 102K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027756 | EDGAR | 101K words |
| 2024-02-22 | 2023-12-31 | 0000950170-24-018797 | EDGAR | 102K words |
| 2023-02-23 | 2022-12-31 | 0000950170-23-004123 | EDGAR | 111K words |
| 2022-02-24 | 2021-12-31 | 0000950170-22-001978 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015518 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-338056 | EDGAR | 60K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269601 | EDGAR | 63K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105054 | EDGAR | 63K words |
| 2025-05-05 | 2025-03-31 | 0000950170-25-063553 | EDGAR | 59K words |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122332 | EDGAR | 58K words |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091837 | EDGAR | 57K words |
| 2024-05-02 | 2024-03-31 | 0000950170-24-052135 | EDGAR | 56K words |
| 2023-11-02 | 2023-09-30 | 0000950170-23-058237 | EDGAR | 61K words |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039874 | EDGAR | 61K words |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017894 | EDGAR | 59K words |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021892 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014809 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-338013 | EDGAR | 3K words |
| 2026-03-16 | 0001193125-26-107312 | EDGAR | 2K words |
| 2026-03-11 | 0001193125-26-102178 | EDGAR | 12K words |
| 2026-02-26 | 0001193125-26-076617 | EDGAR | 3K words |
| 2026-02-03 | 0001193125-26-034422 | EDGAR | 1K words |
| 2025-11-06 | 0001193125-25-269536 | EDGAR | 2K words |
| 2025-08-07 | 0000950170-25-105022 | EDGAR | 2K words |
| 2025-06-11 | 0001193125-25-139146 | EDGAR | 1K words |
| 2025-06-06 | 0001193125-25-137162 | EDGAR | 1K words |
| 2025-06-04 | 0001193125-25-134908 | EDGAR | 1K words |
99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001812364 |
| Ticker | RLAY |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.relaytx.com |
| Listed | 2020-07-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RLAY (~200 tokens, structured JSON with cryptographic provenance)